SARCULATOR
Everyone
info
5K+
Downloads
Everyone
Learn more
About this app
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
The predictive tool for sarcoma pathologies
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
- No data shared with third partiesLearn more about how developers declare sharing
- No data collectedLearn more about how developers declare collection
What’s new
Updated for compatibility with Android 16.
Everyone
Learn moreApp support
About the developer
DIGITAL FOREST SRL
roberto.vergani@digitalforest.it
VIA GIOVANNI CADOLINI 30
20137 MILANO
Italy
+39 346 364 5555
